Quantification of Cyproheptadine (cas 129-03-3) in human plasma by high‐performance liquid chromatography coupled to electrospray tandem mass spectrometry in a bioequivalence study
-
Add time:09/27/2019 Source:infona.pl
A rapid, sensitive and specific method to quantify Cyproheptadine (cas 129-03-3) in human plasma using amitriptyline as the internal standard (IS) is described. The analyte and the IS were extracted from plasma by liquid‐liquid extraction using a diethyl‐ether/dichloromethane (70/30; v/v) solvent. After removing and drying the organic phase, the extracts were reconstituted with a fixed volume of acetonitrile/water (50/50 v/v) + 0.1% of acetic acid. The extracts were analyzed by high performance liquid chromatography coupled to electrospray tandem mass spectrometry (LC‐MS/MS). Chromatography was performed isocratically using an Alltech Prevail C18 5 µm analytical column, (150 mm x 4.6 mm I.D.). The method had a chromatographic run time of 4 min and a linear calibration curve ranging from 0.05 to 10 ng/mL (r2 > 0.99). The limit of quantification was 0.05 ng/mL. This HPLC/MS/MS procedure was used to assess the bioequivalence of cyproheptadine in two cyproheptadine + cobamamide (4 mg + 1 mg) tablet formulations (Cobactin® [cyproheptadine + cobamamide] test formulation supplied from Zambon Laboratórios Farmacêuticos Ltda. and Cobavital® from Solvay Farma (standard reference formulation)). A single 4 mg + 1 mg [cyproheptadine + cobamamide] dose of each formulation was administered to healthy volunteers. The study was conducted using an open, randomized, two‐period crossover design with a 1‐week washout interval. Since the 90% CI for Cmax and AUCs ratios were all within the 80‐125% bioequivalence limit proposed by the US Food and Drug Administration, it was concluded that the cyproheptadine test formulation (Cobactin®) is bioequivalent to the Cobavital® formulation for both the rate and the extent of absorption of cyproheptadine. Copyright © 2011 John Wiley & Sons, Ltd.
We also recommend Trading Suppliers and Manufacturers of Cyproheptadine (cas 129-03-3). Pls Click Website Link as below: cas 129-03-3 suppliers
Prev:Interaction of Cyproheptadine (cas 129-03-3) hydrochloride with human serum albumin using spectroscopy and molecular modeling methods
Next:A case of paroxysmal nocturnal dystonia responsive to Cyproheptadine (cas 129-03-3): Is it almost always epileptic?) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Reversed-phase high performance liquid chromatographic determination of Cyproheptadine (cas 129-03-3) from urine by solid-phase extraction09/30/2019
- Antisaccade, executive and clinical measures in schizophrenia are unaffected by acute 5HT2A/2C antagonism using Cyproheptadine (cas 129-03-3)09/29/2019
- Preventive effect of Cyproheptadine (cas 129-03-3) hydrochloride in refractory patients with frequent migraine09/28/2019
- A case of paroxysmal nocturnal dystonia responsive to Cyproheptadine (cas 129-03-3): Is it almost always epileptic?10/01/2019
- Interaction of Cyproheptadine (cas 129-03-3) hydrochloride with human serum albumin using spectroscopy and molecular modeling methods09/26/2019
-
Health and Chemical more >


